Chimeric Natural Killer Receptor Universal T-cells (CNK-UT)

BIOLOGICAL3 trials

Sponsors

Fujian Medical University, First Affiliated Hospital of Zhejiang University, Nanjing Children's Hospital

Conditions

Acute Graft-versus-Host DiseaseGraft vs Host DiseaseNeuroblastoma, Recurrent, Refractory

Phase 1

Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD

RecruitingNCT06568328

Fujian Medical UniversityGraft vs Host Disease

Start: 2024-09-01End: 2026-08-31Target: 17Updated: 2024-08-23

Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma

RecruitingNCT06751134

Nanjing Children's HospitalNeuroblastoma, Recurrent, Refractory

Start: 2024-12-28End: 2026-12-01Target: 12Updated: 2025-02-07

Universal CNK-UT Therapy for Refractory aGVHD

RecruitingNCT06750133

First Affiliated Hospital of Zhejiang UniversityAcute Graft-versus-Host Disease

Start: 2024-12-14End: 2026-06-30Target: 23Updated: 2024-12-27